Noona Healthcare joins Varian

Noona captures cancer patient-reported outcomes (PROs) with its intuitive mobile service that enables patients to communicate directly with cancer clinics and share information on their recovery process.

“PROs represent a growing and significant metric in evidence-based clinical care and translational research,” says Dow Wilson, president and chief executive officer at Varian. “With this acquisition, Varian gains new partnerships with life-sciences and pharma companies as the Noona software app is used to engage patients, collect PRO data, manage patient communications and enable clinical studies that will test the efficacy of treatment modalities when treating cancer.”

Noona’s intuitive user interface is set to be combined with Varian’s 360 Oncology SaaS platform to offer a robust solution for patients to actively engage with their cancer care team during treatment, recovery and post-treatment.

“The combination of the Noona software app with Varian’s 360 Oncology is a natural fit,” says Jani Ahonala, chief executive officer at Noona Healthcare. “With this acquisition, we have the opportunity to expand the global availability of the Noona technology to the clinical community and elevate the voice of the patient in their cancer care.”

Founded in 2014, Noona Healthcare soon stoked interest in the US and raised substantial seed funding to help with its growth globally.